Tailoring Ovarian Cancer Treatment: Implications of

BRCA mutation PARP inhibitor homologous recombination ovarian cancer platinum resistance treatment

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
23 Mar 2019
Historique:
received: 05 02 2019
revised: 13 03 2019
accepted: 18 03 2019
entrez: 27 3 2019
pubmed: 27 3 2019
medline: 27 3 2019
Statut: epublish

Résumé

High grade serous ovarian cancer (HGSOC) is the most common epithelial ovarian cancer, harbouring more than 20% germline or somatic mutations in the tumour suppressor genes

Identifiants

pubmed: 30909618
pii: cancers11030416
doi: 10.3390/cancers11030416
pmc: PMC6468364
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

J Clin Oncol. 2011 Sep 20;29(27):3628-35
pubmed: 21844495
Br J Cancer. 2012 Aug 7;107(4):588-91
pubmed: 22836511
Mol Cell. 2001 Feb;7(2):273-82
pubmed: 11239456
J Clin Invest. 2016 Aug 1;126(8):2903-18
pubmed: 27454287
JAMA. 2011 Jun 8;305(22):2295-303
pubmed: 21642681
Ann Oncol. 2017 Apr 1;28(4):727-732
pubmed: 27993805
Ann Intern Med. 1982 Dec;97(6):845-51
pubmed: 6890785
Science. 2011 Mar 25;331(6024):1565-70
pubmed: 21436444
J Clin Oncol. 2012 Jul 20;30(21):2654-63
pubmed: 22711857
Int J Gynecol Cancer. 2011 Feb;21(2):289-95
pubmed: 21270612
Ann Oncol. 2019 Jul 1;30(7):1080-1087
pubmed: 31046082
Sci Rep. 2017 Jul 4;7(1):4574
pubmed: 28676659
Nat Rev Mol Cell Biol. 2012 Jun 20;13(7):411-24
pubmed: 22713970
Oncotarget. 2016 Mar 22;7(12):13587-98
pubmed: 26871470
Hum Mol Genet. 2001 Apr;10(7):705-13
pubmed: 11257103
Cancer. 2012 Jan 15;118(2):321-5
pubmed: 21913181
Cancer Chemother Pharmacol. 2004 Dec;54(6):497-504
pubmed: 15258697
Int Immunol. 2007 Jul;19(7):813-24
pubmed: 17606980
Cancer Sci. 2011 Apr;102(4):663-9
pubmed: 21205087
Int J Gynecol Cancer. 2007 May-Jun;17(3):561-70
pubmed: 17504373
Mol Cell Biol. 2006 Dec;26(24):9377-86
pubmed: 17000754
Ann Oncol. 2015 May;26(5):914-920
pubmed: 25722380
J Clin Oncol. 2010 Jul 1;28(19):3107-14
pubmed: 20516432
J Clin Oncol. 2002 Mar 1;20(5):1248-59
pubmed: 11870167
Lancet. 2017 Oct 28;390(10106):1949-1961
pubmed: 28916367
N Engl J Med. 2012 Jun 28;366(26):2455-65
pubmed: 22658128
Eur J Cancer. 2012 Oct;48(15):2361-8
pubmed: 22541893
Clin Cancer Res. 2017 Jul 15;23(14):3711-3720
pubmed: 28167507
Int J Gynecol Pathol. 1992 Jul;11(3):180-7
pubmed: 1399227
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Int J Hyperthermia. 2018 Jun;34(4):407-414
pubmed: 28705099
J Natl Cancer Inst. 2003 Sep 3;95(17):1320-9
pubmed: 12953086
Gynecol Oncol. 2016 Mar;140(3):443-9
pubmed: 26740259
Proc Natl Acad Sci U S A. 2011 Jun 14;108(24):9851-6
pubmed: 21555554
J Cell Mol Med. 2018 Aug;22(8):3979-3986
pubmed: 29855141
Science. 2009 Jun 12;324(5933):1457-61
pubmed: 19460966
J Clin Oncol. 1997 Jun;15(6):2183-93
pubmed: 9196130
Proc Natl Acad Sci U S A. 2007 Aug 7;104(32):13062-7
pubmed: 17656556
Lancet Oncol. 2015 Jan;16(1):87-97
pubmed: 25481791
Gynecol Oncol. 2016 Jan;140(1):42-7
pubmed: 26556769
Cancer. 2012 Feb 15;118(4):899-907
pubmed: 21761396
N Engl J Med. 2018 Jan 18;378(3):230-240
pubmed: 29342393
Cancer. 2007 Feb 15;109(4):692-702
pubmed: 17238181
Cancer Discov. 2012 Nov;2(11):1048-63
pubmed: 22915751
J Pathol. 2012 Feb;226(3):413-20
pubmed: 22102435
Int J Gynecol Cancer. 2017 Nov;27(9):1842-1849
pubmed: 28763368
Lancet Oncol. 2016 Nov;17(11):1579-1589
pubmed: 27617661
Nature. 2011 Jun 29;474(7353):609-15
pubmed: 21720365
Nature. 2015 May 28;521(7553):489-94
pubmed: 26017449
Eur J Cancer. 2015 Feb;51(3):352-8
pubmed: 25534295
Cell Cycle. 2013 Oct 1;12(19):3159-64
pubmed: 24013427
Eur J Cancer. 2017 Oct;84:290-303
pubmed: 28846956
J Clin Oncol. 2014 May 20;32(15):1547-53
pubmed: 24567435
Bioessays. 2004 Aug;26(8):882-93
pubmed: 15273990
Immunol Lett. 2017 Nov;191:35-39
pubmed: 28919454
Nature. 2005 Apr 14;434(7035):917-21
pubmed: 15829967
N Engl J Med. 2016 Dec;375(22):2154-2164
pubmed: 27717299
Nat Rev Cancer. 2015 Mar;15(3):181-94
pubmed: 25673086
J Clin Oncol. 2010 Jul 10;28(20):3323-9
pubmed: 20498395
J Manag Care Spec Pharm. 2018 Dec;24(12):1219-1228
pubmed: 30479195
Cancer Res. 2005 Dec 15;65(24):11597-604
pubmed: 16357170
Cancers (Basel). 2018 Feb 21;10(2):
pubmed: 29466291
Clin Cancer Res. 2014 Feb 1;20(3):764-75
pubmed: 24240112
Cochrane Database Syst Rev. 2018 Aug 24;8:CD012464
pubmed: 30141832
Nature. 2018 Aug;560(7716):112-116
pubmed: 30022158
J Clin Oncol. 2010 May 20;28(15):2505-11
pubmed: 20406939
J Clin Oncol. 2015 May 1;33(13):1460-6
pubmed: 25800756
CA Cancer J Clin. 2018 Jul;68(4):284-296
pubmed: 29809280
Clin Cancer Res. 2013 Nov 15;19(22):6322-8
pubmed: 24077350
Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):601-10
pubmed: 19190154
J Clin Oncol. 2017 Apr 10;35(11):1240-1249
pubmed: 28221868
Gynecol Oncol. 2004 Oct;95(1):1-8
pubmed: 15385103
Oncol Lett. 2017 Sep;14(3):3580-3586
pubmed: 28927115
N Engl J Med. 1996 Dec 26;335(26):1950-5
pubmed: 8960474
Clin Cancer Res. 2003 Nov 15;9(15):5721-8
pubmed: 14654557
Gynecol Oncol. 2017 Sep;146(3):484-490
pubmed: 28698009
Cancer Res. 2006 Sep 15;66(18):8949-53
pubmed: 16982732
Cancer Sci. 2004 Nov;95(11):866-71
pubmed: 15546503
Pharm Res. 2015 Jan;32(1):37-46
pubmed: 24962512
Lancet Oncol. 2011 Sep;12(9):852-61
pubmed: 21862407
Cancer Treat Rev. 2016 Nov;50:175-182
pubmed: 27710871
Am J Obstet Gynecol. 2017 Sep;217(3):334.e1-334.e9
pubmed: 28549976
Lancet Oncol. 2015 Aug;16(8):928-36
pubmed: 26115797
Lancet. 2003 Jun 21;361(9375):2099-106
pubmed: 12826431
Mol Cell. 2009 Aug 28;35(4):534-41
pubmed: 19716796
Clin Cancer Res. 2007 Dec 15;13(24):7413-20
pubmed: 18094425
Nat Rev Immunol. 2008 Jun;8(6):467-77
pubmed: 18500231
Ther Adv Med Oncol. 2014 Sep;6(5):229-39
pubmed: 25342990
Clin Cancer Res. 2008 May 15;14(10):3030-5
pubmed: 18483368
BMC Cell Biol. 2003 Jul 16;4:7
pubmed: 12866953
Proc Natl Acad Sci U S A. 2011 Nov 1;108(44):18032-7
pubmed: 22006311
Mod Pathol. 2012 May;25(5):740-50
pubmed: 22282309
Clin Cancer Res. 2013 Oct 1;19(19):5485-93
pubmed: 23922302
Biochem Cell Biol. 2005 Jun;83(3):354-64
pubmed: 15959561
J Surg Oncol. 2014 Nov;110(6):661-5
pubmed: 24962381
Ann Surg Oncol. 2006 Dec;13(12):1702-10
pubmed: 17009163
Ann Oncol. 2011 Jun;22(6):1346-1352
pubmed: 21228333
J Natl Cancer Inst. 2000 May 3;92(9):699-708
pubmed: 10793106
Clin Cancer Res. 2015 Feb 1;21(3):652-7
pubmed: 25398451
N Engl J Med. 2012 Apr 12;366(15):1382-92
pubmed: 22452356
J Clin Oncol. 2014 Oct 20;32(30):3374-82
pubmed: 25225436
J Ovarian Res. 2017 Sep 12;10(1):60
pubmed: 28899430
Gynecol Oncol. 2013 Mar;128(3):493-9
pubmed: 23246380
Lancet Oncol. 2014 Oct;15(11):1207-14
pubmed: 25218906
Lancet Oncol. 2018 Feb;19(2):207-215
pubmed: 29361470
J Clin Oncol. 2001 Feb 15;19(4):1001-7
pubmed: 11181662
N Engl J Med. 2011 Dec 29;365(26):2473-83
pubmed: 22204724
Annu Rev Immunol. 2005;23:515-48
pubmed: 15771580
JAMA. 2011 Oct 12;306(14):1557-65
pubmed: 21990299
J Clin Oncol. 2016 Dec 20;34(36):4354-4361
pubmed: 27998224
Gynecol Oncol. 2012 Aug;126(2):224-8
pubmed: 22579790
Cancers (Basel). 2015 Dec 03;7(4):2360-71
pubmed: 26633515
Gynecol Oncol. 2018 Aug;150(2):324-330
pubmed: 29880284
MedGenMed. 2005 Jun 29;7(2):60
pubmed: 16369438
N Engl J Med. 2011 Dec 29;365(26):2484-96
pubmed: 22204725
Metallomics. 2009;1(4):280-91
pubmed: 20046924
Acta Pharmacol Sin. 2017 Jul;38(7):1038-1047
pubmed: 28414200
Gynecol Oncol. 2017 Nov;147(2):267-275
pubmed: 28882436
J Clin Oncol. 2010 May 20;28(15):2512-9
pubmed: 20406929
Ann Oncol. 2011 Jan;22(1):39-48
pubmed: 20643862
Nat Rev Cancer. 2008 Mar;8(3):193-204
pubmed: 18256616
Lancet. 2010 Jul 24;376(9737):245-51
pubmed: 20609468
Clin Cancer Res. 2010 Sep 15;16(18):4553-60
pubmed: 20823145
Lancet Oncol. 2013 Sep;14(10):1020-6
pubmed: 23948349
Hum Reprod Update. 2011 Jan-Feb;17(1):55-67
pubmed: 20634209
Oncology (Williston Park). 2016 Feb;30(2):166-76
pubmed: 26892153
Ann Surg Oncol. 2012 Feb;19(2):597-604
pubmed: 21732142
Gynecol Oncol. 2009 Apr;113(1):134-42
pubmed: 19168207
N Engl J Med. 1997 May 15;336(20):1401-8
pubmed: 9145676
Expert Rev Anticancer Ther. 2015;15(10):1223-31
pubmed: 26402249
Br J Cancer. 2016 Mar 29;114(7):723-30
pubmed: 27002934
J Clin Oncol. 2015 Jan 20;33(3):244-50
pubmed: 25366685
Gynecol Oncol. 2006 Jun;101(3):436-40
pubmed: 16325893
Ann Oncol. 2016 Mar;27(3):487-93
pubmed: 26681678
Cancer Discov. 2017 Sep;7(9):984-998
pubmed: 28588062
Br J Cancer. 2014 Aug 12;111(4):651-9
pubmed: 25025963
Gynecol Oncol. 2011 Dec;123(3):486-91
pubmed: 21945552
Br J Cancer. 2018 Apr;118(7):933-935
pubmed: 29531322
Nat Commun. 2018 Sep 28;9(1):3970
pubmed: 30266954
Cancer Biol Ther. 2009 Apr;8(7):648-53
pubmed: 19333003
J Clin Oncol. 2001 Jul 15;19(14):3312-22
pubmed: 11454878
Clin Cancer Res. 2014 Oct 1;20(19):5085-96
pubmed: 25117293
Gynecol Oncol. 2016 Feb;140(2):199-203
pubmed: 26723501
Int J Gynecol Cancer. 2014 Mar;24(3):488-95
pubmed: 24457564
Target Oncol. 2016 Jun;11(3):401-15
pubmed: 27169564
Int J Cancer. 1999 Apr 12;81(2):214-8
pubmed: 10188721
Clin Cancer Res. 2017 Aug 1;23(15):4095-4106
pubmed: 28264872
Mol Cell Biol. 2004 Oct;24(19):8504-18
pubmed: 15367671
Lancet Oncol. 2017 Jan;18(1):75-87
pubmed: 27908594
Clin Cancer Res. 2015 Jan 1;21(1):211-20
pubmed: 25348513
JAMA Oncol. 2016 Apr;2(4):482-90
pubmed: 26720728
Lancet Oncol. 2014 Apr;15(4):396-405
pubmed: 24582486
Oncology. 2013;84(4):226-32
pubmed: 23364291
Crit Rev Oncol Hematol. 2014 Feb;89(2):207-16
pubmed: 24071502
J Clin Oncol. 2015 Oct 20;33(30):3409-15
pubmed: 25964244
Clin Cancer Res. 2015 Oct 1;21(19):4257-61
pubmed: 26187614
N Engl J Med. 2018 Dec 27;379(26):2495-2505
pubmed: 30345884
J Clin Oncol. 2012 Feb 1;30(4):372-9
pubmed: 22203755
Am J Pathol. 1998 Oct;153(4):1249-56
pubmed: 9777956
Cochrane Database Syst Rev. 2016 Jan 12;(1):CD005340
pubmed: 26755441
J Clin Oncol. 2003 Sep 1;21(17):3194-200
pubmed: 12860964
Nat Rev Cancer. 2005 Sep;5(9):689-98
pubmed: 16110319
Neoplasia. 2014 Apr;16(4):343-53.e1-2
pubmed: 24862760
Cancer Res. 2008 Apr 15;68(8):2581-6
pubmed: 18413725
Cancer. 2012 Aug 1;118(15):3703-9
pubmed: 22139894
Nature. 2004 Oct 21;431(7011):1011-7
pubmed: 15496928
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S758-65
pubmed: 26350370
Gynecol Oncol. 2015 Jun;137(3):386-91
pubmed: 25818403
Clin Cancer Res. 2017 Aug 1;23(15):4086-4094
pubmed: 28223274
Nat Med. 2011 Jun 26;17(7):875-82
pubmed: 21706030
Nat Commun. 2017 Nov 24;8(1):1751
pubmed: 29170499
Nat Rev Cancer. 2011 Dec 23;12(1):68-78
pubmed: 22193408
Mol Cancer Ther. 2011 Oct;10(10):2000-7
pubmed: 21835933
J Urol. 2017 Oct;198(4):742-743
pubmed: 28905785
Nature. 2008 Feb 28;451(7182):1116-20
pubmed: 18264087
Nature. 2018 Aug;560(7716):117-121
pubmed: 30022168
Cancer Discov. 2012 Nov;2(11):1036-47
pubmed: 22915752
Cancer Discov. 2017 Jun;7(6):620-629
pubmed: 28242752
N Engl J Med. 1999 Feb 4;340(5):351-7
pubmed: 9929525
Int J Gynecol Cancer. 2011 May;21(4):771-5
pubmed: 21543939
Lancet Oncol. 2014 Jul;15(8):852-61
pubmed: 24882434
Clin Cancer Res. 2018 Feb 15;24(4):777-783
pubmed: 29191972
Crit Rev Oncol Hematol. 2007 Nov;64(2):129-38
pubmed: 17566758
Drug Resist Updat. 2016 Nov;29:90-106
pubmed: 27912846
Nat Rev Cancer. 2004 Jun;4(6):423-36
pubmed: 15170445
Lancet Oncol. 2007 Jan;8(1):26-34
pubmed: 17196508
Am J Pathol. 1995 Jul;147(1):33-41
pubmed: 7541612
Br J Cancer. 2013 Apr 2;108(6):1231-7
pubmed: 23462720
Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7606-11
pubmed: 8755522
Lancet Oncol. 2017 Sep;18(9):1274-1284
pubmed: 28754483
Ann Oncol. 2017 Mar 1;28(3):512-518
pubmed: 27993796
Cancer. 2006 May 1;106(9):1933-9
pubmed: 16572412
Mod Pathol. 2014 Oct;27(10):1405-11
pubmed: 24577588
Science. 2017 Jul 28;357(6349):409-413
pubmed: 28596308
Am J Hum Genet. 2003 May;72(5):1117-30
pubmed: 12677558
J Clin Oncol. 2015 Dec 1;33(34):4015-22
pubmed: 26351349
J Clin Oncol. 2006 Oct 10;24(29):4699-707
pubmed: 16966687
Mol Cell. 2012 Apr 27;46(2):125-35
pubmed: 22445484
Cell Res. 2008 Jan;18(1):99-113
pubmed: 18166982
Lancet Oncol. 2013 Aug;14(9):882-92
pubmed: 23810788
N Engl J Med. 2006 Jan 5;354(1):34-43
pubmed: 16394300
Mod Pathol. 2009 Mar;22(3):393-402
pubmed: 19060844
Pharmacogenomics. 2012 Oct;13(13):1523-35
pubmed: 23057551
Breast J. 2015 May-Jun;21(3):260-7
pubmed: 25789811
Proc Natl Acad Sci U S A. 2011 Feb 22;108(8):3406-11
pubmed: 21300883
Acta Oncol. 2002;41(5):418-24
pubmed: 12442916
Cancer Lett. 2015 Dec 28;369(2):363-7
pubmed: 26342406
J Clin Oncol. 2008 Dec 1;26(34):5530-6
pubmed: 18955455

Auteurs

Ainhoa Madariaga (A)

Division of Medical Oncology & Hematology, Princess Margaret Cancer Center, Toronto, ON M5G 2M9, Canada. ainhoa.madariaga@uhn.ca.

Stephanie Lheureux (S)

Division of Medical Oncology & Hematology, Princess Margaret Cancer Center, Toronto, ON M5G 2M9, Canada. stephanie.lheureux@uhn.ca.

Amit M Oza (AM)

Division of Medical Oncology & Hematology, Princess Margaret Cancer Center, Toronto, ON M5G 2M9, Canada. amit.oza@uhn.ca.

Classifications MeSH